SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-16-109791
Filing Date
2016-06-24
Accepted
2016-06-24 16:16:50
Documents
1
Group Members
ACMP IV, LLCDANIEL S. JANNEYGUY P. NOHRA

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v442873_sc13da.htm SC 13D/A 78007
  Complete submission text file 0001144204-16-109791.txt   79754
Mailing Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111 4153624022
ACP IV, L.P. (Filed by) CIK: 0001282908 (see all company filings)

IRS No.: 200580531
Type: SC 13D/A

Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777
Carbylan Therapeutics, Inc. (Subject) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88797 | Film No.: 161731261
SIC: 2834 Pharmaceutical Preparations